000 | 01814 a2200457 4500 | ||
---|---|---|---|
005 | 20250516043651.0 | ||
264 | 0 | _c20111019 | |
008 | 201110s 0 0 eng d | ||
022 | _a1083-351X | ||
024 | 7 |
_a10.1074/jbc.M111.261925 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSchwan, Carsten | |
245 | 0 | 0 |
_aCholesterol- and sphingolipid-rich microdomains are essential for microtubule-based membrane protrusions induced by Clostridium difficile transferase (CDT). _h[electronic resource] |
260 |
_bThe Journal of biological chemistry _cAug 2011 |
||
300 |
_a29356-29365 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
650 | 0 | 4 |
_aAntifungal Agents _xpharmacology |
650 | 0 | 4 |
_aBacterial Adhesion _xdrug effects |
650 | 0 | 4 |
_aBacterial Toxins _xmetabolism |
650 | 0 | 4 | _aCaco-2 Cells |
650 | 0 | 4 |
_aCholesterol _xmetabolism |
650 | 0 | 4 |
_aClostridioides difficile _xenzymology |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 |
_aEnterocolitis, Pseudomembranous _xenzymology |
650 | 0 | 4 |
_aFatty Acids, Monounsaturated _xpharmacology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMembrane Microdomains _xmetabolism |
650 | 0 | 4 |
_aMicrotubules _xmetabolism |
650 | 0 | 4 |
_aNystatin _xpharmacology |
650 | 0 | 4 |
_aSphingolipids _xmetabolism |
650 | 0 | 4 |
_aSphingomyelin Phosphodiesterase _xpharmacology |
650 | 0 | 4 |
_abeta-Cyclodextrins _xpharmacology |
700 | 1 | _aNölke, Thilo | |
700 | 1 | _aKruppke, Anna S | |
700 | 1 | _aSchubert, Daniel M | |
700 | 1 | _aLang, Alexander E | |
700 | 1 | _aAktories, Klaus | |
773 | 0 |
_tThe Journal of biological chemistry _gvol. 286 _gno. 33 _gp. 29356-29365 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1074/jbc.M111.261925 _zAvailable from publisher's website |
999 |
_c20959495 _d20959495 |